Figure 7.

SW33 suppressed glioma growth in vivo. (A) Schematic diagram of GBM xenograft mouse model treated with SW33 in vivo. (B) Image of tumors in different groups treated with SW33 for three weeks. (C) Tumor weight after three weeks of treatment with SW33. (D) Tumor volume during administration of SW33. (E) Body weight during administration of SW33. (F) Relative organ weights after three weeks of treatment with SW33. (G) Changes in spleen weight of different groups after SW33 treatment for three weeks. Data are expressed as mean ± SD (n = 6). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 (D: vs. Vehicle).